Synthetic nanoparticles for gene editing in the brain in utero

Synthetic nanoparticles for gene editing in the brain in utero
2014 Scientific Innovations Award
W. Mark Saltzman, Ph.D.
Department of Biomedical Engineering
Yale University

Dr. Saltzman and his lab propose an innovative and potentially transformative approach for the correction of single-gene disorders of the central nervous system in the fetal brain: in utero administration of synthetic nanoparticles carrying triplex-forming oligonucleotides, which they have shown to be a powerful gene-editing agent. They will optimize nanoparticle size, chemistry, and composition for targeted delivery to fetal brain cells after intra-uterine administration. Dr. Saltzman and his lab will test the effectiveness of this approach by attempting to correct the gene disorder in Hurler Syndrome in mice. If they are successful, this novel approach can be applied to any monogenic gene defect in the brain. Further, our nanoparticles—which will be produced from biocompatible materials–can potentially be used for the in utero delivery of any agent and therefore may be useful for treating a wide range of diseases in the brain.

Other Awards

Angelique Bordey, Ph.D., Yale University
The Role of Ribosomes in Synaptic Circuit Formation and Socio-Communicative Deficits
Our proposal aims at identifying a molecular mechanism responsible for autism-like socio-communicative defects in the developmental disorder, tuberous sclerosis complex (TSC). TSC is a genetic disorder with a 30-60% incidence…
Adam E. Cohen, Ph.D., The University of North Carolina at Chapel Hill
To spike or not to spike? Mapping dendritic computations in vivo.
The brain is made of neurons, and neurons convert synaptic inputs to spiking outputs. How does a neuron decide when to spike?
Gina Turrigiano, Ph.D., Brandeis University
Homeostatic Maintenance of Neocortical Excitation-inhibition Balance by Ciliary Neuropeptidergic Signaling
Brain circuit wiring is adjusted during adolescence to generate fully functional circuits, and this process depends on an interaction between genetics and experience. During this period of experience-dependent development, excitatory…
Gregory Scherrer, Ph.D., The University of North Carolina at Chapel Hill
Mechanisms of Affective States and Drug Discovery at the Intersection of Chronic Pain and Opioid Addiction
Pain is normally a sensation that we experience when our body is exposed to damaging stimuli, such as the noxious heat of an open flame. However, when chronic, pain becomes…